ilrnalvv


  • A scientific scramble for space

    first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

  • A tale of two developers

    first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

  • China’s CanSino defends coronavirus vaccine candidate after experts cast doubt

    first_imgIt is unscientific to compare the antibody levels generated by different vaccine candidates so far, because varied testing methods could distort results, Zhu said.AstraZeneca Plc on Tuesday said it paused a late-stage trial of one of its leading experimental viral vector-based vaccine, which uses a technology similar to CanSino’s, after an unexplained illness in a study participant.The hiccup does not mean all viral-vector based experimental vaccines are risky, Zhu said, adding that it was not rare for clinical trials to be paused.CanSino’s shares were up 6% at HK$181.50 ($23.42) on Wednesday afternoon in Hong Kong. He said there were instances in which vaccines created using methods doubted by experts had obtained regulatory approvals after clinical trials proved they worked.No evidence showed that existing antibodies against the common cold could have a major adverse impact on Ad5-nCoV’s ability to trigger antibodies against the novel coronavirus, Zhu said, citing results from 128 participants tested with a lower dose of the vaccine candidate in a mid-stage trial.Ad5-nCoV, still in final-stage trials, has been approved for use in the Chinese military.Vaccine companies normally have to collect data in large-scale, late-stage trials to obtain regulatory approval for mass use. China’s CanSino Biologics Inc said on Wednesday that expert opinion on its high-profile coronavirus vaccine candidate should not be followed “blindly” without sufficient clinical trial data.Scientists outside the company have expressed concern that the effectiveness of CanSino’s candidate Ad5-nCoV, which is based on a common cold virus to which many people have been exposed, could be limited. They said existing antibodies against the common cold virus might undermine Ad5-nCoV.”Vaccine development is a practice-based science, and we should not blindly follow experts,” Zhu Tao, chief scientific officer, said during an investor conference.center_img Topics :last_img read more

  • Building supplies scheme seeking new provider

    first_imgThe €333m Dutch Pensioenfonds Rockwool is considering its options for switching to new provider, after the employer and the unions indicated that they wanted to make a change this year.In a newsletter, the scheme – which serves current and former employees of building supplies company Rockwool – said the social partners’ involvement had accelerated its exploration of options, a process that had already started at the request of regulator De Nederlandsche Bank (DNB).The scheme’s supervisory board andt accountability body had also both urged the main board to come up with a vision for its future.The pension fund and the social partners are considering transferring future accrual to a new provider, and moving existing pension rights and legacy benefits to another party. In both scenarios, the sponsor would terminate its contract with the pension fund.The Pensioenfonds Rockwool said it was exploring the possibilities of joining another pension fund for future accrual and placing its other pension rights with an insurer or a general pension fund (APF).It added that it was also considering the option of moving its pensions to a provider in Belgium.However, the Rockwool scheme said its choices would be limited because of its low funding position of 100.4% at November-end.The social partners and the pension fund said they wanted to involve members in their search for a solution through a survey.The Pensioenfonds Rockwool has almost 1,200 active participants and reported administration costs of €366 per participant for 2017.During 2017, asset management costs rose from 33 to 69 basis points, which the scheme in part attributed to a switch from NN IP to Northern Trust, changing its actively managed equity mandate into a passively managed one. NN IP, however, stayed on as fiduciary manager for the pension fund.The Rockwool scheme has a 30% allocation to equity, with the remainder of its portfolio invested in fixed income.last_img read more

  • US cancer institute signs agreement to import vaccine developed in Cuba

    first_img Share BusinessHealthInternationalLifestylePrint US cancer institute signs agreement to import vaccine developed in Cuba by: Caribbean Media Corporation – April 23, 2015 Tweet HAVANA, Cuba (CMC) – Cuba’s Centre of Molecular Immunology and New York’s Roswell Park Cancer Institute, have signed an agreement to export to the United States, a therapeutic vaccine against lung cancer developed here. “The agreement will allow us to limit ourselves to clinical trials of the vaccine when we get to New York,” said Candace Johnson, the director of the Roswell Park Cancer Institute.Johnson was part of a trade delegation from New York, led by governor, Andrew Cuomo, to explore business options here, in addition to promoting exchanges in education and research.“We are excited to bring the vaccine to the US and treating patients. This would not have been possible without this trade mission, which facilitated the initialling of the agreement face to face, “said JohnsonThe vaccine against lung cancer was created in Cuba in 2011 after 15 years of research with patent rights worldwide.The vaccine – Cimivax, reportedly doubles as a treatment for lung cancer.The vaccine is registered in Cuba and Peru, although countries like Brazil, Argentina and Colombia are in the process for registration, and others such as the UK and Australia have conducted clinical trials. Sharecenter_img 203 Views   no discussions Sharing is caring! Sharelast_img read more

  • January 15, 2018 Police Blotter

    first_imgJanuary 15, 2018 Police Blotter011518 Batesville Police Blotter011518 Decatur County EMS Report011518 Decatur County Fire Report011518 Decatur County Jail Report011518 Decatur County Law Reportlast_img

  • Taylor Gait’s hamstring injury derails redshirt junior’s season

    first_imgTaylor Gait’s hamstring injury put her out two weeks. Rushing back sidelined her for two more.On March 12, as Syracuse prepped for then-No. 3 Florida, Gait initially strained her hamstring. The team had been traveling a lot in recent days — a six-hour bus ride to Maryland followed by a four-and-a-half-hour plane ride to Florida — and Gait felt her hamstring tighten but thought nothing of it. When the pain became too unbearable she sat out and SU’s midfielder with a history of knee injuries now had a new ailment to worry about.As SU readied itself for Duke two weeks later, Gait ran for the first time and hurt herself again. The Fayetteville, New York, native strained her hamstring in a different spot and found her way back on the bench.“I couldn’t even walk,” Gait said. “I’m getting there. I haven’t done much.”Ally Moreo | Photo EditorAdvertisementThis is placeholder textThirty-three days and eight games have come and gone since the initial injury and Gait has played just once. SU went 1-3 in the first four games without the midfielder. But new players have stepped up, launching the No. 11 Orange (12-4, 5-1 Atlantic Coast) on a four-game win streak, including an upset of No. 2 North Carolina in Chapel Hill on Saturday. Two more injuries to sophomore attack Nicole Levy and senior defense Haley McDonnell thinned SU’s roster even further, and made Gait’s return more important. Yet, despite practicing more and feeling better, Gait has no timetable for return and head coach Gary Gait believes she’s going at half speed.Against Virginia Tech on April 9, Gait saw her first action in about a month. The decision to return was sudden, just like her poorly timed injury. During the 12-11 overtime win, one of SU’s coaches walked over to Gait and asked her if she felt ready. She responded yes and ran onto the field, and the crowd cheered.“Being up against a zone definitely helped,” Gait said. “It was good to get out there.”The Hokies’ zone defense meant less cutting, dodging and, for Gait, less of a chance to reinjure her hamstring. Gait didn’t record a point and her limp was noticeable at times, but after the game, both Taylor and Gary were smiling. They knew it was a step in the right direction. Though, in SU’s next game against No. 2 UNC, Gait stood on the sideline, watching her team upset the Tar Heels, 13-11.SU has coped with Gait’s injury thanks to the emergence of two underclassmen: sophomore Natalie Wallon (19 goals, two assists) and redshirt freshman Mary Rahal (23 goals, six assists). But the margin for error has been slim. The Orange has won its last four games by a combined nine goals. A lower-body injury suffered by Nicole Levy on April 5 against Loyola has only made matters worse.“We follow the lead of our medical staff,” Gary Gait said of the injuries to Levy and Taylor. “Between our doctors and our trainers, we try to get them back as soon as possible.”Two games remain on SU’s regular season schedule before postseason play — Gait’s self-determined return date. April 11 marked Gait’s first full day of practice after the injury. One day later, she could barely run.Her trainer has left it up to her. If the hamstring feels fine, Gait will practice knowing the soreness will follow soon after. If not, Gait begrudgingly plants her feet on SU’s sideline, where she’s been stuck for the past month.“I’m still going to take it easy,” Gait said. “I don’t know how much I’ll play. We’ll see but I really don’t know.” Comments Facebook Twitter Google+ Published on April 16, 2017 at 10:45 pm Contact Nick: nialvare@syr.edu | @nick_a_alvarezlast_img read more

  • Football: Wisconsin, Purdue to be the Big Ten showdown that will shake up Madison

    first_imgThe University of Wisconsin football team is meeting the Purdue Boilermakers to the gridiron this weekend in what is sure to be a challenging game for the Badgers.Wisconsin has a lot to lose this game, considering that they are walking into this weekend’s matchup with an undefeated record of 6-0. The only other team in the Big Ten that is still undefeated at this point in the season is Penn State, to whom the Badgers lost the Big Ten Championship to last year.Football: Wisconsin dominates in Lincoln winning Freedom Trophy for fourth straight yearIt looks as though the University of Wisconsin is getting back into the swing of things after managing to take Read…UW also has been supporting some major player this season who have managed to earn national accolades as the weeks progress.For starters, you have Wisconsin quarterback Alex Hornibrook who is currently ranked eight in the nation. Hornibrook is the only quarterback in the Big Ten who is in the top ten nationally in passing efficiency, and has managed to break a school record this year against BYU.Hornibrook is joined by freshman running back Jonathan Taylor, who is making some big waves during his first year with the Badgers. Taylor is ranked 11th for all-purpose yardage, 4th for rushing yardage and 9th in overall scoring. Taylor’s performance thus far this season has drawn so much attention to him that he is now a candidate for the Heisman trophy.While Wisconsin is being lead by a dominant team this year, that does not mean they have not been through their fair share of struggles as the season progresses. The Badgers have usually started off most games at home with a meek performance during the first half of the game, followed by an outstanding second half performance.While UW has managed to produce six wins this season, being consistently good throughout both halves of play is something this team is still working on. The same momentum they have been managing to generate during the second half of the game somehow needs to be replicated during the first half of the game.Purdue has been managing to get the ball rolling quite well for themselves this season, as they currently have a 3-2 record this season and are ranked 3rd in the Big Ten West.Although the Boilermakers had a tougher schedule ahead of them than Wisconsin had, they have still been managing to churn out some high quality wins, including last weekend where they crushed Minnesota in a game everyone thought the Gophers would win.Wisconsin football struggles against Northwestern, still squeaks out winUsually, taking a week off bodes well for teams, but the University of Wisconsin football team came back from their Read…Although they might not be ranked in any of the major categories so far this season, Purdue is a team that Wisconsin should be cautious about come Saturday. They are not to be underestimated and will pose a serious challenge to the UW —  one that might even result in the first loss of the season if the Badgers aren’t careful enough.The Badgers and the Boilermakers will face off at 11 a.m. at Camp Randall, and anyone who finds themselves without tickets to this thrilling game should watch on Big Ten Network, because this is sure to be a true gridiron battle.Correction: A previous version of this post misstated the game will begin at 11 a.m. The article has been updated to reflect the correct time. The Badger Herald regrets this error.last_img read more

  • More resources needed for underage coaching

    first_imgFollowing the progression of the Inter County Minor teams, in both hurling and football, to this year’s All Ireland Finals, there has been some criticism of the underage provisions in the county. There are several dual players on the minor teams for this year, following on from their loss in the All Ireland final on Sunday; they now are facing into a football All Ireland against Kerry in two weeks time. David Power, Wexford senior football manager and manager of the Tipp minor footballers who won the All Ireland in 2011 says despite the success of this year’s minor teams….there are serious problems at underage level in the county.last_img

  • Power faring well in the US

    first_imgHe’s in a tie for 21st on 7 under par.Power shot a round of 70 last night.last_img